Jaguar health, inc. (JAGX)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Jun'14Mar'14
Cash flows from operating activities
Net loss

-7,936

-5,959

-7,555

-16,720

-8,304

-12,653

-6,138

-7,657

-5,696

-20,207

4,759

-1,805

-4,715

-3,657

-3,984

-4,130

-2,960

-5,262

-3,937

-1,943

-1,966

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

432

432

431

436

437

329

329

329

329

258

296

15

15

9

7

-

-

-

-

-

-

Interest paid on the conversion of debt to equity

-

-

-

-

-

0

38

-39

-20

-

-

-

-

-

-

-

-

-

-

-

-

Common stock issued in exchange for services rendered

-

-

-

-

-

-

0

0

6

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and debt discount

-

-

-

-

-

-

-

-

-

-

-

83

96

137

131

127

86

1,660

845

-

-

Change in fair value of warrants and conversion option liability

-

-

-

-

-

-

-

-

-

-

-

-

453

-

-

-

-

-

-

-

-

Accretion of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

5

Warrants issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

173

328

-

-

Loss on extinguishment of debt

-

0

-335

-2,663

-1,942

-

-

-

-

-269

0

0

-207

-

-

-

-

-

-

-

-

Amortization of operating lease right-of-use-assets

191

-362

191

306

56

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Expense on modification of warrants

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Materials cost in connection with license activity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

6

0

1,082

Stock-based compensation

760

1,005

1,110

445

427

607

680

464

272

183

186

216

228

125

103

164

200

575

52

-

-

Amortization of debt issuance costs and debt discount

14

125

1,152

3,701

178

-264

643

414

403

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of warrants, conversion option and derivative liability

-1

-6

-841

-207

46

172

-37

-409

267

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3

Changes in assets and liabilities
Accounts receivable

-609

98

-503

1,182

-81

-32

445

220

-104

-291

450

12

-4

6

-43

47

-20

21

8

-

-

Other receivable

1

13

-92

90

-4

-170

105

68

1

-15

-180

-90

288

-

-

-

-

-

-

-

-

Inventory

575

-193

-71

-566

-382

792

-294

515

255

241

-352

3

-20

6

39

-26

-50

-7

116

-

-

Prepaid expenses and other current assets

-189

-218

713

-97

-150

-524

-150

916

-130

-112

198

-27

85

-

-

-

-

-

-

-

-

Prepaid license fee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-100

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

224

301

-29

204

26

98

7

25

Deferred offering costs

-

-

-

-

-

-

-

-

-

-303

293

-54

-7

-

-

-

-

-

-

-

-

Other non-current assets

-27

-

-

-

-27

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred collaboration revenue

-

-

-

-

-

0

0

0

-177

-

-

-637

2,088

-

-

-

-

-

-

-

-

Operating lease liabilities

-119

213

-116

-137

-93

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-11

-

-

Due from former parent

-

-

-

-

-

-

-

-

-

0

-242

-0

78

2

0

1

1

-26

4

-17

-35

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-16

-

-

-

-

-

-

-

-

Deferred product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-16

27

-84

-36

-15

365

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

0

1

1

-

-

-

-

-

-

License fee payable

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-425

-525

-500

-150

-25

-

-

Accounts payable

191

599

-1,638

-173

1,150

-1,036

1,449

1,838

-4,192

-502

1,781

1,978

931

-216

101

181

-50

-1,434

1,063

-49

242

Accrued expenses

191

-555

-1,570

1,015

52

889

1,897

1,307

-834

272

-315

-498

683

76

-193

123

199

-1,059

190

719

-20

Total cash used in operating activities

-4,296

-3,139

-8,546

-5,306

-3,465

-4,902

-2,810

-5,396

-9,621

-5,330

-3,028

-1,177

-288

-

-

-

-

-

-

-

-

Total cash used in operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,527

-3,929

-3,355

-5,691

-1,338

-1,163

-613

Cash flows from investing activities
Purchase of equipment

7

-

-

-

-

0

0

0

6

-

-

-

-

12

85

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,676

-178

-

-

-

-

-

-

Total cash used in investing activities

-7

-

-

-

-

0

0

0

-6

-

-

-

-

-

-

-

-

-

-

-

-

Total cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

93

-

-

-

-

-

-

Cash flows from financing activities
Proceeds from issuance of notes payable, net of issuance costs and debt discount

350

0

0

4,250

800

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loan advance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

-

-

Repayment of notes payable

-

-

-

-

-

-

-

-

-

260

1,169

501

490

1,676

178

-

-

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,777

4,880

Proceeds from issuance of convertible debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,000

250

-

-

Proceeds from issuance of long term debt

-

-

-

-

-

-

-

0

2,310

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of notes payable

50

100

4,950

0

100

-

-

0

1,689

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock

-

-

-

-

2,769

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of underwriting discounts, commissions and other associated offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

21

386

10

824

205

Proceeds from issuance of common stock through a stock purchase agreement with a private investor

-

-

-

-

-

-

0

0

1,305

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock in follow-on secondary public offering, net of commissions, discounts

-

-

-

-

-

-

-

-

-

-

-

-

-

0

5,000

-

-

-

-

-

-

Total cash provided by financing activities

2,023

4,953

9,002

4,347

3,469

6,744

1,124

-0

16,676

5,369

2,545

2,712

52

-

-

-

-

-

-

-

-

Net increase in cash and restricted cash

-2,280

1,813

462

-965

4

1,842

-1,685

-5,396

7,048

27

-2,028

1,534

-236

-

-

-

-

-

-

-

-

Supplemental schedule of cash flow information
Cash paid for interest

6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Cash Provided by Financing Activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,951

-250

5,856

17,324

1,240

1,252

4,675

Net decrease in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,339

-483

-2,679

-2,001

11,632

-98

33

4,062

Supplemental schedule of non-cash financing and investing activities
Interest paid on long-term debt

-

-

-

-

-

-

-

0

19

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividend

-

-

-

-

-

-

-

-1,990

995

-

-

-

-

-

-

0

0

159

187

205

79

Warrants issued in connection with convertible notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

47

-

0

Abatement of license fee payable to Napo

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

250

-

0

Common stock issued in exchange for CVP Exchange Note 1 principal and related interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

525

Accretion to redemption value of Series A redeemable convertible preferred stock

-480

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fixed assets in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

817

Series B convertible preferred stock
Series B convertible preferred stock inducement expense

1,647

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series 2 warrants
Proceeds from issuance of common stock

708

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series 1 warrants
Proceeds from issuance of common stock

144

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2019 Bridge Note Warrants
Proceeds from issuance of common stock

173

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Private Investment in Public Entities
Proceeds from the issuance of convertible preferred stock

698

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Private Investment in Public Entities March 2018
Proceeds from the issuance of convertible preferred stock, March 2018

-

-

-

-

-

199

0

-199

9,199

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of common stock

-

-

-

-

-

-

0

0

5,000

-

-

-

-

-

-

-

-

-

-

-

-

Issuance costs associated with the issuance of convertible preferred stock, March 2018

-

-

-

-

-

-

-

-

-199

-

-

-

-

-

-

-

-

-

-

-

-

Private Investment in Public Entities December 2017
Proceeds from the issuance of common stock

-

-

-

-

-

-

-

-

750

-

-

-

-

-

-

-

-

-

-

-

-

Notes payable
Common stock issued as redemption of notes payable and related interest

-

-

-

-

4,821

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of warrants

-

-

-

-

893

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Jaguar Notes Payable
Common stock issued as redemption of notes payable and related interest

-

-

-

-

-

0

0

203

950

-

-

-

-

-

-

-

-

-

-

-

-

Napo convertible debt
Common stock issued as redemption of notes payable and related interest

-

-

-

-

-

0

479

0

1,158

-

-

-

-

-

-

-

-

-

-

-

-

March 2019 letter of credit warrant
Issuance of warrants

-

-

-

-

116

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series A convertible preferred stock
Accretion to redemption value of Series A redeemable convertible preferred stock

480

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series B-2 convertible preferred stock
Conversion of Series B-2 convertible preferred stock into common stock

320

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-